These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 38059681

  • 1. Frequency of skin cancer among psoriasis, vitiligo, and mycosis fungoides patients treated with narrowband ultraviolet B phototherapy.
    Mimouni I, Shulman J, Unes AA, Pavlovsky L, Pavlotsky F.
    Photodermatol Photoimmunol Photomed; 2024 Jan; 40(1):e12936. PubMed ID: 38059681
    [Abstract] [Full Text] [Related]

  • 2. Predictors of adherence to Narrowband ultraviolet B first-month treatment dosage plan.
    Pavlotsky F, Alkhazov A, Barzilai A, Scope A.
    Isr Med Assoc J; 2022 Dec; 25(12):820-823. PubMed ID: 36573776
    [Abstract] [Full Text] [Related]

  • 3. Incidence of skin malignancies in patients with vitiligo or psoriasis who received narrowband ultraviolet B phototherapy (308 nm/311 nm): A retrospective review of 3730 patients.
    Chia BKY, Yew YW, Zhao X, Chong WS, Thng TGS.
    Photodermatol Photoimmunol Photomed; 2023 Jul; 39(4):343-350. PubMed ID: 36345565
    [Abstract] [Full Text] [Related]

  • 4. A large scale analytical study on efficacy of different photo(chemo)therapeutic modalities in the treatment of psoriasis, vitiligo and mycosis fungoides.
    El-Mofty M, Mostafa WZ, Bosseila M, Youssef R, Esmat S, El Ramly A, Fawzi M, Mahgoub D, Nagui N, Mashaly HM, El-Fangary M, Fathy M.
    Dermatol Ther; 2010 Jul; 23(4):428-34. PubMed ID: 20666832
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of narrowband UVB phototherapy in early-stage mycosis fungoides in Iranian patients.
    Shirzadian Kebria A, Asghari J, Tirgar Tabari S, Aryanian Z, Shirafkan H.
    Lasers Med Sci; 2022 Oct; 37(8):3231-3235. PubMed ID: 35838846
    [Abstract] [Full Text] [Related]

  • 6. Risk of skin cancer in psoriasis patients receiving long-term narrowband ultraviolet phototherapy: Results from a Taiwanese population-based cohort study.
    Lin TL, Wu CY, Chang YT, Juan CK, Chen CC, Yu SH, Chen YJ.
    Photodermatol Photoimmunol Photomed; 2019 May; 35(3):164-171. PubMed ID: 30536640
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Nb-UVB and PUVA therapy in treating early stages of Mycosis Fungoides: A single-center cross-sectional study.
    Zengarini C, Baruffaldi G, Piraccini BM, Bardazzi F, Mussi M, Hrvatin Stancic B, Pileri A.
    Photodermatol Photoimmunol Photomed; 2023 Sep; 39(5):435-440. PubMed ID: 36974002
    [Abstract] [Full Text] [Related]

  • 9. A retrospective, descriptive study of patients with Mycosis fungoides treated by phototherapy (oral PUVA, NB-UVB) with a twice-weekly regimen at the Institute of Dermatology, Bangkok, Thailand, with an experiential timeline of 13 years.
    Pattamadilok B, Poomputsar T.
    Photodermatol Photoimmunol Photomed; 2021 Jan; 37(1):49-55. PubMed ID: 32964521
    [Abstract] [Full Text] [Related]

  • 10. An Update on Narrowband Ultraviolet B Therapy for the Treatment of Skin Diseases.
    Myers E, Kheradmand S, Miller R.
    Cureus; 2021 Nov; 13(11):e19182. PubMed ID: 34873522
    [Abstract] [Full Text] [Related]

  • 11. The effect of NB-UVB on noncultured melanocyte and keratinocyte transplantation in treatment of generalized vitiligo using two different donor-to-recipient ratios.
    Tawfik YM, Abd Elazim NE, Abdel-Motaleb AA, Mohammed RAA, Tohamy AMA.
    J Cosmet Dermatol; 2019 Apr; 18(2):638-646. PubMed ID: 30280485
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Treatment outcome and persistence of repigmentation from narrow-band ultraviolet B phototherapy in vitiligo.
    Silpa-Archa N, Weerasubpong P, Junsuwan N, Yothachai P, Supapueng O, Wongpraparut C.
    J Dermatolog Treat; 2019 Nov; 30(7):691-696. PubMed ID: 30474443
    [Abstract] [Full Text] [Related]

  • 14. Topical Band-pass Filter Cream (TBFC)-assisted home-based NB-UVB: A must-know Alternative to artificial phototherapy.
    Sonthalia S.
    J Cosmet Dermatol; 2021 Jul; 20(7):2141-2147. PubMed ID: 33977652
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of Biological Effects and Transcriptome Changes Induced by LED-Based Narrow-Band UVB Phototherapy.
    Liu X, Chen H, Li Z, Duan L, Yang X, Jiang P, Xu L, Gong Y, Han K.
    Photochem Photobiol; 2022 Nov; 98(6):1379-1389. PubMed ID: 35538716
    [Abstract] [Full Text] [Related]

  • 16. The impact of therapeutic modalities on patients with atopic dermatitis, psoriasis and vitiligo treated with phototherapy in the Jagiellonian University Outpatient Clinic.
    Englert K, Kłosowicz A, Pelc P, Pastuszczak M, Wojas-Pelc A.
    Pol Merkur Lekarski; 2019 Mar 28; 46(273):125-129. PubMed ID: 30912521
    [Abstract] [Full Text] [Related]

  • 17. Narrowband UVB and PUVA in the treatment of mycosis fungoides: a retrospective study.
    Ahmad K, Rogers S, McNicholas PD, Collins P.
    Acta Derm Venereol; 2007 Mar 28; 87(5):413-7. PubMed ID: 17721648
    [Abstract] [Full Text] [Related]

  • 18. A cross-sectional analysis of skin cancer risk in patients receiving narrow-band ultraviolet B phototherapy: an evaluation of 100 patients.
    Karaosmanoglu N, Ozdemir Cetinkaya P, Kutlu O, Karaaslan E, Imren IG, Kiratli Nalbant E, Eksioglu M.
    Arch Dermatol Res; 2020 May 28; 312(4):249-253. PubMed ID: 31729594
    [Abstract] [Full Text] [Related]

  • 19. Narrow-band ultraviolet B phototherapy for early stage mycosis fungoides.
    Xiao T, Xia LX, Yang ZH, He CD, Gao XH, Chen HD.
    Eur J Dermatol; 2008 May 28; 18(6):660-2. PubMed ID: 18955199
    [Abstract] [Full Text] [Related]

  • 20. Potential of narrow-band ultraviolet B to induce sustained durable complete remission off-therapy in patients with stage I mycosis fungoides.
    Pavlotsky F, Dawood M, Barzilai A.
    J Am Acad Dermatol; 2019 Jun 28; 80(6):1550-1555. PubMed ID: 29800582
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.